跳至主要内容
临床试验/JPRN-UMIN000014286
JPRN-UMIN000014286暂停未知

First-in-human study of I-123 IIMU. - First-in-human study of I-123 IIMU.

Hokkaido University Hospital0 个研究点目标入组 8 人开始时间: 2014年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • (1) a history of hepatic or renal disease. (2) a history of hypersensitivity for medical drugs. (3) a history of drug abuse. (4) a participation of other clinical trial within 6 months before enrollment. (5) any medical treatment including vitamin drug and Kanpo-drug within 14 days before enrollment. (6) a donation of plasma to a blood bank or clinical study within 14 days before enrollment. a donation of over 200 ml whole blood to a blood bank or clinical study within 28 days before enrollment. a donation of over 400 ml whole blood to a blood bank or clinical study within 84 days before enrollment. a donation of over 800 ml whole blood to a blood bank or clinical study within 365 days before enrollment. (7) a history of iodine allergy. (8)And subjects were excluded if the investigators judged as misfit for this study.

研究者

相似试验

First-in-human study of I-123 IIMU. | 临床试验